Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$25.91 +3.3%	$22.32	$19.10 ▼ $29.55	$1.20B	1.76	557,506 shs	652,188 shs
ESTA Establishment Labs	$43.63 +9.1%	$40.95	$26.56 ▼ $50.85	$1.16B	0.83	490,249 shs	389,764 shs
MDXG MiMedx Group	$7.31 +4.0%	$6.65	$5.47 ▼ $10.14	$1.04B	1.79	802,109 shs	1.08 million shs
TCMD Tactile Systems Technology	$13.23 +4.2%	$10.78	$8.61 ▼ $21.10	$283.11M	0.96	269,642 shs	192,645 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	+3.31%	+6.45%	+15.41%	+18.96%	+0.74%
ESTA Establishment Labs	+9.08%	+13.86%	+1.04%	+19.14%	-0.95%
MDXG MiMedx Group	+3.98%	+2.81%	+5.48%	+10.26%	+11.26%
TCMD Tactile Systems Technology	+4.17%	+6.61%	+26.24%	+40.45%	+4.17%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLFS BioLife Solutions	2.5497 of 5 stars	2.6	3.0	3.5	2.5	0.6
ESTA Establishment Labs	1.9306 of 5 stars	3.4	0.0	2.0	2.5	0.6
MDXG MiMedx Group	3.2618 of 5 stars	3.5	4.0	3.2	1.7	0.6
TCMD Tactile Systems Technology	2.4813 of 5 stars	1.2	3.0	2.4	2.5	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	3.13	Buy	$31.29	20.75% Upside
ESTA Establishment Labs	2.83	Moderate Buy	$56.50	29.50% Upside
MDXG MiMedx Group	3.00	Buy	$12.00	64.16% Upside
TCMD Tactile Systems Technology	2.40	Hold	$13.50	2.04% Upside

Current Analyst Ratings Breakdown

Latest TCMD, BLFS, MDXG, and ESTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2025	ESTA Establishment Labs	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$60.00
8/11/2025	BLFS BioLife Solutions	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/8/2025	BLFS BioLife Solutions	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $32.00
8/5/2025	TCMD Tactile Systems Technology	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/5/2025	TCMD Tactile Systems Technology	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$12.00 ➝ $13.00
7/31/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$11.00 ➝ $12.00
7/22/2025	BLFS BioLife Solutions	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$30.00
7/16/2025	ESTA Establishment Labs	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$58.00 ➝ $70.00
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/9/2025	ESTA Establishment Labs	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$38.00 ➝ $47.00
6/13/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$82.25M	15.09	$0.13 per share	204.71	$7.25 per share	3.57
ESTA Establishment Labs	$177.42M	7.12	N/A	N/A	$0.79 per share	55.23
MDXG MiMedx Group	$348.88M	3.10	$0.34 per share	21.22	$1.46 per share	5.01
TCMD Tactile Systems Technology	$292.98M	1.01	$1.13 per share	11.73	$8.74 per share	1.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$20.18M	-$0.12	N/A	N/A	N/A	-5.39%	0.16%	0.14%	11/11/2025 (Estimated)
ESTA Establishment Labs	-$84.60M	-$3.05	N/A	N/A	N/A	-49.89%	-224.34%	-25.53%	11/6/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.21	34.81	22.84	N/A	8.84%	23.03%	17.09%	10/29/2025 (Estimated)
TCMD Tactile Systems Technology	$16.96M	$0.62	21.34	15.75	N/A	5.06%	7.72%	5.59%	11/3/2025 (Estimated)

Latest TCMD, BLFS, MDXG, and ESTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	BLFS BioLife Solutions	-$0.02	-$0.33	-$0.31	-$0.33	$23.71 million	$25.42 million
8/7/2025	Q2 2025	ESTA Establishment Labs	-$0.54	-$0.57	-$0.03	-$0.57	$50.80 million	$51.30 million
8/4/2025	Q2 2025	TCMD Tactile Systems Technology	$0.09	$0.14	+$0.05	$0.14	$73.93 million	$78.91 million
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	$0.10	+$0.04	$0.06	$90.79 million	$98.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
TCMD Tactile Systems Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	N/A	4.43	3.45
ESTA Establishment Labs	9.71	2.84	1.67
MDXG MiMedx Group	0.08	4.39	3.90
TCMD Tactile Systems Technology	0.11	3.79	3.36

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
ESTA Establishment Labs	72.91%
MDXG MiMedx Group	79.15%
TCMD Tactile Systems Technology	83.43%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
ESTA Establishment Labs	11.09%
MDXG MiMedx Group	1.70%
TCMD Tactile Systems Technology	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	440	47.90 million	46.85 million	Optionable
ESTA Establishment Labs	1,018	28.97 million	25.76 million	Optionable
MDXG MiMedx Group	870	147.96 million	145.44 million	Optionable
TCMD Tactile Systems Technology	1,037	22.29 million	21.74 million	Optionable

TCMD, BLFS, MDXG, and ESTA Headlines

Recent News About These Companies

Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?

August 22 at 10:40 AM | zacks.com

Tactile Systems Technology, Inc. $TCMD Shares Sold by Tocqueville Asset Management L.P.

August 20 at 6:05 AM | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) CEO Sheri Louise Dodd Sells 7,762 Shares

August 14, 2025 | marketbeat.com

Koss Olinger Consulting LLC Takes Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

August 11, 2025 | marketbeat.com

Blair William & Co. IL Reduces Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

August 10, 2025 | marketbeat.com

Tactile Systems Technology (NASDAQ:TCMD) Upgraded by Wall Street Zen to Buy Rating

August 10, 2025 | marketbeat.com

What is B. Riley's Estimate for TCMD Q1 Earnings?

August 8, 2025 | marketbeat.com

Q3 Earnings Forecast for TCMD Issued By William Blair

August 8, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Hold" from Analysts

August 7, 2025 | marketbeat.com

William Blair Upgrades Tactile Systems Technology (NASDAQ:TCMD) to Strong-Buy

August 7, 2025 | marketbeat.com

B. Riley Analysts Reduce Earnings Estimates for TCMD

August 7, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Call Transcript

August 7, 2025 | msn.com

B. Riley Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock Price

August 6, 2025 | marketbeat.com

Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now?

August 6, 2025 | zacks.com

Tactile Systems Technology (TCMD) Just Overtook the 20-Day Moving Average

August 6, 2025 | zacks.com

Tactile Systems Technology (TCMD) Recently Broke Out Above the 50-Day Moving Average

August 6, 2025 | zacks.com

Tactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growth

August 6, 2025 | msn.com

Tactile Systems Technology (NASDAQ:TCMD) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

August 5, 2025 | marketbeat.com

Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript

August 4, 2025 | seekingalpha.com

Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates

August 4, 2025 | zacks.com

Tactile Systems (TCMD) Q2 Revenue Up 8%

August 4, 2025 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD, BLFS, MDXG, and ESTA Company Descriptions

BioLife Solutions NASDAQ:BLFS

$25.91 +0.83 (+3.31%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$25.91 +0.00 (+0.00%)

As of 08/22/2025 05:09 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Establishment Labs NASDAQ:ESTA

$43.63 +3.63 (+9.08%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$43.64 +0.01 (+0.02%)

As of 08/22/2025 07:39 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

MiMedx Group NASDAQ:MDXG

$7.31 +0.28 (+3.98%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$7.30 0.00 (-0.07%)

As of 08/22/2025 04:10 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Tactile Systems Technology NASDAQ:TCMD

$13.23 +0.53 (+4.17%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$13.22 -0.01 (-0.04%)

As of 08/22/2025 06:59 PM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time